Type II diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group: In addition to the usual treatments for diabetes we treat patients with 6 capsules containing 3 Nigella sativa daily at a dose of 170 milligram, Fenugreek with a do
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: Fasting blood sugar is equal to or higher than 126 milligram per millileter Taking oral hypoglycemic drugs Consumption of a fixed dose of oral hypoglycemic drugs for at least the last 3 months Lack of kidney failure Lack of type 1 diabetes Lack of acute and chronic inflammatory diseases Lack of malignancy Lack of drug addiction No pregnancy or lactation
Exclusion criteria
Exclusion criteria: Dissatisfaction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cytokine TGF-ß. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine TNF?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IFN-?. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Cytokine IL-17. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Number of Treg cells. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test.;Nitric oxide measurement. Timepoint: Before intervention and 6 weeks after the treatment. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mehdi Salehi
Arak University of Medical Sciences
Outcome results
None listed